drugset / Trial / NCT07059377
Semaglutide for Smoking Cessation in Patients With Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the feasibility of conducting a randomized controlled trial (RCT) to determine the effectiveness of semaglutide as an adjunct to combination NRT in supporting smoking cessation for patients with diabetes.
Timeline
- Start
- 2026-02-13
- Primary completion
- 2026-07
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 0.5 mg | — |
| Subject | Semaglutide | Peptide | 2 mg | — |
| Background | Nicotine | Unknown | — | — |